David M. Lowe

10.2k citations

110 papers · 6.4k indexed · 2 hit papers · h-index 37

Impact in

Pollution top 0.2%
- Microplastics and Plastic Pollution
Health, Toxicology and Mutagenesis top 0.2%
- Environmental Toxicology and Ecotoxicology

Papers in

Infectious Diseases 30
- Tuberculosis Research and Epidemiology 11
- SARS-CoV-2 and COVID-19 Research 9
Immunology 27
- Immunodeficiency and Autoimmune Disorders 19

Co-authors: Tamara S. Galloway Awantha Dissanayake Mark A. Oakley Browne Richard C. Thompson Michael N. Moore A. Viarengo Angela Köehler B. L. Bayne
Journals: Journal of Clinical Immunology (7 papers)Frontiers in Immunology (4 papers)The Journal of Allergy and Clinical Immunology In Practice (4 papers)PLoS ONE (4 papers)Marine Biology (3 papers)
Partner nations: United Kingdom Germany South Africa

In The Last Decade

David M. Lowe

103 papers receiving 6.1k citations

Hit Papers

align trajectories log scale

Ingested Microscopic Plastic Translocates to the Circulatory System of the Mussel, Mytilus edulis (L.) 2008 · 1.8k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Environmental Science & Technology
2007 Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology

Peers

Countries citing papers authored by David M. Lowe

Since Specialization

Citations

This map shows the geographic impact of David M. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Lowe more than expected).

Fields of papers citing papers by David M. Lowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Lowe. The network helps show where David M. Lowe may publish in the future.

Co-authors

The 25 scholars most cited alongside David M. Lowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David M. Lowe Line = papers co-authored together David M. Lowe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2 Journal of Clinical Investigation ·Shadisadat Esmaeili, Katherine Owens, Ugo Avila-Ponce de León, Joseph F. Standing, David M. Lowe, Shengyuan Zhang, James A Watson, William HK Schilling, Jessica Wagoner, Stephen J. Polyak, Joshua T. Schiffer	2025	0
2	Pre-Transplant Immune Dysregulation Predicts for Poor Outcome Following Allogeneic Haematopoietic Stem Cell Transplantation in Adolescents and Adults with Inborn Errors of Immunity (IEI) Journal of Clinical Immunology ·Thomas A. Fox, Valérie Massey, Charley Lever, Rachel Pearce, Arian Laurence, Sarah Grace, Fabiana Oliviero, Sarita Workman, Andrew Symes, David M. Lowe, Valeria Fiaccadori, Rachael Hough, Susan Tadros, Siobhan O. Burns, Markus G. Seidel, Ben Carpenter, Emma Morris	2025	0
3	Skin Manifestations in Adults With Chronic Granulomatous Disease in the United Kingdom The Journal of Allergy and Clinical Immunology In Practice ·Luiza C. Campos, C. Arteaga Henríquez, George Meligonis, Susan Tadros, David M. Lowe, Bodo Grimbacher, Siobhan O. Burns, Catherine H. Orteu	2025	0
4	Favipiravir induces HuNoV viral mutagenesis and infectivity loss with clinical improvement in immunocompromised patients Clinical Immunology ·Alexandra Y. Kreins, Emma Roux, Juanita Pang, Iek Cheng, Oscar Charles, Sunando Roy, Reem Mohammed, Stephen Owens, David M. Lowe, Ruairı́ Brugha, Rachel C. Williams, Evey Howley, Timothy Best, E. Graham Davies, Austen Worth, Caroline Solas, Joseph F. Standing, Richard A. Goldstein, Joana Rocha‐Pereira, Judith Breuer	2024	4
5	Common variable immunodeficiency disorder (CVID)-related liver disease: assessment of the main histological aspects using novel semiquantitative scoring systems, image analysis and correlation with clinical parameters of liver stiffness and portal hypertension Journal of Clinical Pathology ·Hiroshi Silva, Camila Gabriela Xavier de Brito, Andrew Hall, Nadia Eden, Henry Somers, Niall Burke, Siobhan O. Burns, David M. Lowe, Douglas Thorburn, Neil Halliday, Alberto Quaglia	2023	5
6	Immunoglobulin Replacement Therapy During COVID-19 Pandemic: Practical and Psychological Impact in Patients with Antibody Deficiency Journal of Clinical Immunology ·Jesmeen Maimaris, A.K. O’Sullivan, Isabella Underhill, Ghiselle Green, Andrew Symes, David M. Lowe, Siobhan O. Burns, Mari Campbell, Reem Elfeky	2023	1
7	Recurrent Campylobacter jejuni Infections with In Vivo Selection of Resistance to Macrolides and Carbapenems: Molecular Characterization of Resistance Determinants Microbiology Spectrum ·Alexandra Nunes, Mónica Oleastro, Frederico Alves, Nadia Liassine, David M. Lowe, Lucie Bénéjat, Astrid Ducounau, Quentin Jehanne, Vítor Borges, João Paulo Gomes, Gauri Godbole, Lehours Philippe	2023	8
8	Impact of prophylactic and ‘rescue pack’ antibiotics on the airway microbiome in chronic lung disease BMJ Open Respiratory Research ·Sylvia Rofael, James Brown, Marc Lipman, David M. Lowe, David A. Spratt, Shumonta Quaderi, John R. Hurst, Timothy D. McHugh	2023	10
9	Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients Journal of Clinical Immunology ·Michele Chan, Me Me Nay Linn, Thomas O’Hagan, José Afonso Guerra‐Assunção, Angie Lackenby, Sarita Workman, Anna Dacre, Siobhan O. Burns, Judith Breuer, Jennifer Hart, Susan Tadros, David M. Lowe	2023	15
10	Executable network of SARS-CoV-2-host interaction predicts drug combination treatments npj Digital Medicine ·Rowan S. M. Howell, Matthew A. Clarke, Ann‐Kathrin Reuschl, Tianyi Chen, Sean Abbott-Imboden, Mervyn Singer, David M. Lowe, Clare L. Bennett, Benny Chain, Clare Jolly, Jasmin Fisher	2022	10
11	Comparative assessment of viral dynamic models for SARS‐CoV‐2 for pharmacodynamic assessment in early treatment trials British Journal of Clinical Pharmacology ·Akosua Adom Agyeman, Tao You, Phylinda L. S. Chan, D Lonsdale, Christoforos Hadjichrysanthou, Tabitha Mahungu, Emmanuel Wey, David M. Lowe, Marc Lipman, Judith Breuer, Frank Kloprogge, Joseph F. Standing	2022	3
12	Chronic Granulomatous Disorder–Associated Colitis Can Be Accurately Evaluated with MRI Scans and Fecal Calprotectin Level Journal of Clinical Immunology ·David M. Lowe, Philip J Smith, Fernando Moreira, Sarita Workman, Helen Braggins, Nikolaos Koukias, Matthew Buckland, Peter Wylie, Stuart A. Taylor, Charles Murray	2019	4
13	Absence of Persistent Hepatitis E Virus Infection in Antibody-Deficient Patients Is Associated With Transfer of Antigen-Neutralizing Antibodies From Immunoglobulin Products The Journal of Infectious Diseases ·Mike Ankcorn, Fernando Moreira, Samreen Ijaz, Andrew Symes, Matthew Buckland, Sarita Workman, Fiona Warburton, Richard S. Tedder, David M. Lowe	2018	7
14	The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis PLoS ONE ·Nishtha Jhilmeet, David M. Lowe, Catherine Riou, Thomas J. Scriba, Anna K. Coussens, René Goliath, Robert J. Wilkinson, Katalin A. Wilkinson	2018	2
15	Differential Effect of Viable Versus Necrotic Neutrophils on Mycobacterium tuberculosis Growth and Cytokine Induction in Whole Blood Frontiers in Immunology ·David M. Lowe, Julie Demaret, Nonzwakazi Bangani, Justine K. Nakiwala, René Goliath, Katalin A. Wilkinson, Robert J. Wilkinson, Adrian R. Martineau	2018	31
16	Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir – Case series and 10 year experience of management in an adult transplant cohort Journal of Clinical Virology ·Isobel Ramsay, Charlotte Attwood, Dianne Irish, Paul Griffiths, Charalampia Kyriakou, David M. Lowe	2017	36
17	Blood Neutrophil Counts in HIV-Infected Patients with Pulmonary Tuberculosis: Association with Sputum Mycobacterial Load PLoS ONE ·Andrew D. Kerkhoff, Robin Wood, David M. Lowe, Monica Vogt, Stephen D Lawn	2013	21
18	Neutrophils in tuberculosis: friend or foe? Trends in Immunology ·David M. Lowe, Paul S. Redford, Robert J. Wilkinson, Anne O’Garra, Adrian R. Martineau	2011	248
19	Dangerous Doughty – A quantitative study of disproportion between the size of endotracheal tubes and splits in tonsillectomy gag blades The Journal of Laryngology & Otology ·David M. Lowe, Tim Hoare	2002	2
20	7TH NERVE PALSY AFTER EXTRADURAL BLOOD PATCH British Journal of Anaesthesia ·David M. Lowe, Allison McCullough	1990	18

About David M. Lowe

David M. Lowe is a scholar working on Infectious Diseases, Immunology, Health, Toxicology and Mutagenesis, Virology and Epidemiology, having authored 110 papers that have together received 6.4k indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (19 papers), Marine Bivalve and Aquaculture Studies (17 papers), Environmental Toxicology and Ecotoxicology (16 papers), Tuberculosis Research and Epidemiology (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Cystic Fibrosis Research Advances (8 papers) and Marine Biology and Environmental Chemistry (7 papers). The work is most often cited by research in Pollution (2.4k citations), Health, Toxicology and Mutagenesis (2.0k citations), Industrial and Manufacturing Engineering (1.1k citations), Oceanography (749 citations) and Global and Planetary Change (1.1k citations). David M. Lowe has collaborated with scholars based in United Kingdom, Germany and South Africa. Frequent co-authors include Tamara S. Galloway, Awantha Dissanayake, Mark A. Oakley Browne, Richard C. Thompson, Michael N. Moore, A. Viarengo, Angela Köehler, B. L. Bayne, Claudia Bolognesi and Elena Fabbri. Their work appears in journals such as Journal of Clinical Immunology, Frontiers in Immunology, The Journal of Allergy and Clinical Immunology In Practice, PLoS ONE and Marine Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact